Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
70 studies found for:    prodromal
Show Display Options
Rank Status Study
1 Withdrawn C1-INH Compared to Placebo at the Time of Prodromal Symptoms for Hereditary Angioedema (HAE) Exacerbation
Condition: Hereditary Angioedema
Interventions: Drug: C-1-esterase;   Drug: placebo
2 Unknown  Psychological Intervention for Persons in the Early Initial Prodromal State
Conditions: Schizophrenia;   Psychosis
Interventions: Behavioral: Cognitive behavioral therapy (CBT);   Behavioral: Supportive Counselling (SC)
3 Completed Glycine Treatment of Prodromal Symptoms
Condition: Schizophrenia
Intervention: Drug: glycine
4 Recruiting Efficacy and Safety Trial of MK-8931 in Participants With Prodromal Alzheimer's Disease (MK-8931-019)
Conditions: Amnestic Mild Cognitive Impairment;   Alzheimer's Disease;   Prodromal Alzheimer's Disease
Interventions: Drug: MK-8931;   Drug: Placebo
5 Terminated A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Avagacestat;   Drug: Placebo
6 Recruiting A Study to Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: JNJ-54861911 10 mg;   Drug: JNJ-54861911 50 mg;   Drug: Placebo
7 Completed Aripiprazole Treatment of Prodromal Patients
Conditions: Schizophrenia;   Psychosis
Intervention: Drug: Aripiprazole
8 Active, not recruiting Isotopic Imaging for Prodromal Alzheimer's Disease
Condition: Alzheimer Disease
9 Unknown  Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis
Conditions: Schizophrenia;   Psychoses
Interventions: Behavioral: Clinical Management (CM);   Drug: Amisulpride
10 Recruiting A Study of Gantenerumab in Patients With Prodromal Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: gantenerumab;   Drug: placebo
11 Active, not recruiting Psychosis: Early Detection, Intervention and Prevention
Conditions: Prodromal Schizophrenia;   Psychotic Disorders;   Severe Bipolar Disorder With Psychotic Features;   Severe Major Depression With Psychotic Features
Interventions: Behavioral: Family-aided Assertive Community Treatment;   Behavioral: Enhanced standard treatment
12 Recruiting Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation
Condition: Granulin Mutation
Interventions: Drug: FRM-0334;   Drug: Placebo
13 Recruiting Multiple Dose Study of BIIB037 (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: BIIB037 (recombinant, fully human anti-Aβ IgG1 mAb);   Drug: Placebo
14 Recruiting Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression
Condition: Parkinson Disease
Intervention: Drug: Datscan and AV-133
15 Recruiting " The Eyes Have it " : Ocular Saccade Abnormalities in Prodromal Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Other: Neuropsychological assessment;   Other: ophthalmologic checkup;   Other: Automated non-invasive oculometry
16 Completed Ethyl-EPA Treatment of Prodromal Patients
Condition: Schizophrenia Prodrome
Intervention: Drug: ethyl-eicosapentaenoic acid
17 Recruiting Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Conditions: Schizophrenia;   Cannabis Dependence;   Prodromal for Psychotic Illness;   Family History of Alcoholism
Intervention: Radiation: [11-C]OMAR
18 Not yet recruiting Multi-site Communication Deficits in Schizophrenia
Conditions: Schizophrenia;   Psychosis
19 Active, not recruiting NAPLS Omega-3 Fatty Acid Versus Placebo Study
Condition: Psychosis
Interventions: Drug: Omega-3 Long Chain Fatty Acid;   Drug: Placebo
20 Recruiting Pathogenesis of Atypical Femur Fractures on Long Term Bisphosphonate Therapy
Conditions: Osteoporosis;   Atypical Femoral Fractures;   Prodromal Bone Deterioration
Interventions: Other: 500 without BP treatment;   Other: 500 with BP treatment

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years